(Q53377599)

13 May 2018

title

Papillomaviruses: a correlation between immune evasion and oncogenicity? (English)

1 reference

13 May 2018

evasion of host immune response

main subject

1 reference

Philippa M O'Brien

1

1 reference

13 May 2018

M Saveria Campo

series ordinal

2

1 reference

13 May 2018

publication date

1 July 2003

1 reference

13 May 2018

published in

Trends in Microbiology

1 reference

13 May 2018

volume

11

1 reference

13 May 2018

page(s)

300-305

1 reference

13 May 2018

issue

7

1 reference

13 May 2018

HLA control in the progression of human papillomavirus infections.

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0966-842X%2803%2900145-8

7 January 2021

HLA and susceptibility to cervical neoplasia

1 reference

https://api.crossref.org/works/10.1016%2FS0966-842X%2803%2900145-8

7 January 2021

Environmental co-factors in HPV carcinogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0966-842X%2803%2900145-8

7 January 2021

Potential strategies utilised by papillomavirus to evade host immunity

1 reference

https://api.crossref.org/works/10.1016%2FS0966-842X%2803%2900145-8

7 January 2021

The causal relation between human papillomavirus and cervical cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0966-842X%2803%2900145-8

7 January 2021

The human papillomavirus E6 protein and its contribution to malignant progression

1 reference

https://api.crossref.org/works/10.1016%2FS0966-842X%2803%2900145-8

7 January 2021

Biological activities and molecular targets of the human papillomavirus E7 oncoprotein

1 reference

https://api.crossref.org/works/10.1016%2FS0966-842X%2803%2900145-8

7 January 2021

Comparative analysis of the intracellular location of the high- and low-risk human papillomavirus oncoproteins

1 reference

https://api.crossref.org/works/10.1016%2FS0966-842X%2803%2900145-8

7 January 2021

Human papillomavirus infection and cervical intraepithelial neoplasia in women with renal allografts

1 reference

https://api.crossref.org/works/10.1016%2FS0966-842X%2803%2900145-8

7 January 2021

Bovine papillomavirus and cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0966-842X%2803%2900145-8

7 January 2021

Human papillomavirus infection and non-melanoma skin cancer in immunosuppressed and immunocompetent individuals.

1 reference

https://api.crossref.org/works/10.1016%2FS0966-842X%2803%2900145-8

7 January 2021

Increased risk of cervical disease among human immunodeficiency virus-infected women with severe immunosuppression and high human papillomavirus load(1).

1 reference

https://api.crossref.org/works/10.1016%2FS0966-842X%2803%2900145-8

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0966-842X%2803%2900145-8

7 January 2021

Immunology of papillomavirus infection.

1 reference

https://api.crossref.org/works/10.1016%2FS0966-842X%2803%2900145-8

7 January 2021

Immune evasion in human papillomavirus-associated cervical cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0966-842X%2803%2900145-8

7 January 2021

Evasion of host immunity directed by papillomavirus-encoded proteins

1 reference

https://api.crossref.org/works/10.1016%2FS0966-842X%2803%2900145-8

7 January 2021

Down-regulation of MHC class I by bovine papillomavirus E5 oncoproteins

1 reference

https://api.crossref.org/works/10.1016%2FS0966-842X%2803%2900145-8

7 January 2021

The bovine papillomavirus oncoprotein E5 retains MHC class I molecules in the Golgi apparatus and prevents their transport to the cell surface

1 reference

https://api.crossref.org/works/10.1016%2FS0966-842X%2803%2900145-8

7 January 2021

Persistence of type-specific human papillomavirus infection among cytologically normal women

1 reference

https://api.crossref.org/works/10.1016%2FS0966-842X%2803%2900145-8

7 January 2021

A population-based five-year follow-up study of cervical human papillomavirus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0966-842X%2803%2900145-8

7 January 2021

Viral mechanisms of immune evasion

1 reference

https://api.crossref.org/works/10.1016%2FS0966-842X%2803%2900145-8

7 January 2021

Human papillomavirus 16 E6 oncoprotein binds to interferon regulatory factor-3 and inhibits its transcriptional activity

1 reference

https://api.crossref.org/works/10.1016%2FS0966-842X%2803%2900145-8

7 January 2021

The human papilloma virus (HPV)-18 E6 oncoprotein physically associates with Tyk2 and impairs Jak-STAT activation by interferon-alpha

1 reference

https://api.crossref.org/works/10.1016%2FS0966-842X%2803%2900145-8

7 January 2021

Inactivation of interferon regulatory factor-1 tumor suppressor protein by HPV E7 oncoprotein. Implication for the E7-mediated immune evasion mechanism in cervical carcinogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0966-842X%2803%2900145-8

7 January 2021

The human papillomavirus E7 protein is able to inhibit the antiviral and anti-growth functions of interferon-alpha

1 reference

https://api.crossref.org/works/10.1016%2FS0966-842X%2803%2900145-8

7 January 2021

Transcriptional regulation of the major histocompatibility complex (MHC) class I heavy chain, TAP1 and LMP2 genes by the human papillomavirus (HPV) type 6b, 16 and 18 E7 oncoproteins.

1 reference

https://api.crossref.org/works/10.1016%2FS0966-842X%2803%2900145-8

7 January 2021

Human papillomavirus type 18 associates with more advanced cervical neoplasia than human papillomavirus type 16

1 reference

https://api.crossref.org/works/10.1016%2FS0966-842X%2803%2900145-8

7 January 2021

Human papillomavirus type 18: association with poor prognosis in early stage cervical cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0966-842X%2803%2900145-8

7 January 2021

Identification of adenovirus E1A regions which affect MHC class I expression and susceptibility to cytotoxic T lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0966-842X%2803%2900145-8

7 January 2021

The MHC-encoded TAP1/LMP2 bidirectional promoter is down-regulated in highly oncogenic adenovirus type 12 transformed cells

1 reference

https://api.crossref.org/works/10.1016%2FS0966-842X%2803%2900145-8

7 January 2021

HLA expression in pre-invasive cervical neoplasia in relation to human papilloma virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0966-842X%2803%2900145-8

7 January 2021

Analysis of MHC class I and II expression in relation to presence of HPV genotypes in premalignant and malignant cervical lesions

1 reference

https://api.crossref.org/works/10.1016%2FS0966-842X%2803%2900145-8

7 January 2021

Interaction of human papillomavirus type 11 E7 protein with TAP-1 results in the reduction of ATP-dependent peptide transport

1 reference

https://api.crossref.org/works/10.1016%2FS0966-842X%2803%2900145-8

7 January 2021

Human papillomavirus variants and squamous neoplasia of the cervix

1 reference

https://api.crossref.org/works/10.1016%2FS0966-842X%2803%2900145-8

7 January 2021

T cell responses and virus evolution: loss of HLA A11-restricted CTL epitopes in Epstein-Barr virus isolates from highly A11-positive populations by selective mutation of anchor residues

1 reference

https://api.crossref.org/works/10.1016%2FS0966-842X%2803%2900145-8

7 January 2021

Mutation "hot spot" in HLA class I-restricted T cell epitope on hepatitis B surface antigen in chronic carriers and hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0966-842X%2803%2900145-8

7 January 2021

Variation of human papillomavirus type 6 (HPV-6) and HPV-11 genomes sampled throughout the world

1 reference

https://api.crossref.org/works/10.1016%2FS0966-842X%2803%2900145-8

7 January 2021

The association of an HPV16 oncogene variant with HLA-B7 has implications for vaccine design in cervical cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0966-842X%2803%2900145-8

7 January 2021

Immunogenetic factors in HPV-associated cervical cancer: influence on disease progression

1 reference

https://api.crossref.org/works/10.1016%2FS0966-842X%2803%2900145-8

7 January 2021

Degradation of p53 can be targeted by HPV E6 sequences distinct from those required for p53 binding and trans-activation

1 reference

https://api.crossref.org/works/10.1016%2FS0966-842X%2803%2900145-8

7 January 2021

Human papillomavirus genotype as a predictor of persistence and development of high-grade lesions in women with minor cervical abnormalities

1 reference

https://api.crossref.org/works/10.1016%2FS0966-842X%2803%2900145-8

7 January 2021

Human papillomavirus type 16 sequence variation in cervical cancers: a worldwide perspective

1 reference

https://api.crossref.org/works/10.1016%2FS0966-842X%2803%2900145-8

7 January 2021

Human papillomavirus type 16 variant lineages characterized by nucleotide sequence analysis of the E5 coding segment and the E2 hinge region

1 reference

https://api.crossref.org/works/10.1016%2FS0966-842X%2803%2900145-8

7 January 2021

Cervical lesions are associated with human papillomavirus type 16 intratypic variants that have high transcriptional activity and increased usage of common mammalian codons.

1 reference

https://api.crossref.org/works/10.1016%2FS0966-842X%2803%2900145-8

7 January 2021

Binding of human papillomavirus 16 E5 to the 16 kDa subunit c (proteolipid) of the vacuolar H+-ATPase can be dissociated from the E5-mediated epidermal growth factor receptor overactivation

1 reference

https://api.crossref.org/works/10.1016%2FS0966-842X%2803%2900145-8

7 January 2021

10.1016/S0966-842X(03)00145-8

Identifiers

DOI

1 reference

13 May 2018

PubMed ID

12875812

1 reference

13 May 2018